Cite
HARVARD Citation
Eggermont, A. et al. (2020). Adjuvant therapy with pegylated interferon-alfa2b vs observation in stage II B/C patients with ulcerated primary: Results of the European Organisation for Research and Treatment of Cancer 18081 randomised trial. European journal of cancer. pp. 94-103. [Online].